Vertongen P - Search Results

1

Presence of calcitonin gene-related peptide receptors coupled to adenylate cyclase in human gliomas.

Robberecht P, De Neef P, Woussen-Colle MC, Vertongen P, De Witte O, Brotchi J. Robberecht P, et al. Among authors: vertongen p. Regul Pept. 1994 Jun 16;52(1):53-60. doi: 10.1016/0167-0115(94)90021-3. Regul Pept. 1994. PMID: 7972932

2

Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.

Vertongen P, Langlet C, Langer I, Gaspard N, Robberecht P. Vertongen P, et al. Peptides. 2004 Nov;25(11):1943-9. doi: 10.1016/j.peptides.2004.06.001. Peptides. 2004. PMID: 15501526

3

Expression of pituitary adenylate cyclase activating polypeptide and receptors in human brain tumors.

Vertongen P, d'Haens J, Michotte A, Velkeniers B, van Rampelbergh J, Svoboda M, Robberecht P. Vertongen P, et al. Peptides. 1995;16(4):713-9. doi: 10.1016/0196-9781(95)00036-j. Peptides. 1995. PMID: 7479307

4

Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide stimulate two signaling pathways in CHO cells stably transfected with the selective type I PACAP receptor.

Delporte C, Poloczek P, de Neef P, Vertongen P, Ciccarelli E, Svoboda M, Herchuelz A, Winand J, Robberecht P. Delporte C, et al. Among authors: vertongen p. Mol Cell Endocrinol. 1995 Jan;107(1):71-6. doi: 10.1016/0303-7207(94)03424-r. Mol Cell Endocrinol. 1995. PMID: 7796937

5

Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23.

Vertongen P, Ciccarelli E, Woussen-Colle MC, De Neef P, Robberecht P, Cauvin A. Vertongen P, et al. Endocrinology. 1994 Oct;135(4):1537-42. doi: 10.1210/endo.135.4.7925114. Endocrinology. 1994. PMID: 7925114

6

Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors in human glial cell tumors.

Robberecht P, Woussen-Colle MC, Vertongen P, De Neef P, Hou X, Salmon I, Brotchi J. Robberecht P, et al. Among authors: vertongen p. Peptides. 1994;15(4):661-5. doi: 10.1016/0196-9781(94)90092-2. Peptides. 1994. PMID: 7937342

7

Receptors for pituitary adenylate cyclase activating peptides in human pituitary adenomas.

Robberecht P, Vertongen P, Velkeniers B, de Neef P, Vergani P, Raftopoulos C, Brotchi J, Hooghe-Peters EL, Christophe J. Robberecht P, et al. Among authors: vertongen p. J Clin Endocrinol Metab. 1993 Nov;77(5):1235-9. doi: 10.1210/jcem.77.5.8077316. J Clin Endocrinol Metab. 1993. PMID: 8077316

8

The long-acting vasoactive intestinal polypeptide agonist RO 25-1553 is highly selective of the VIP2 receptor subclass.

Gourlet P, Vertongen P, Vandermeers A, Vandermeers-Piret MC, Rathe J, De Neef P, Waelbroeck M, Robberecht P. Gourlet P, et al. Among authors: vertongen p. Peptides. 1997;18(3):403-8. doi: 10.1016/s0196-9781(96)00322-1. Peptides. 1997. PMID: 9145428

9

Development of high affinity selective VIP1 receptor agonists.

Gourlet P, Vandermeers A, Vertongen P, Rathe J, De Neef P, Cnudde J, Waelbroeck M, Robberecht P. Gourlet P, et al. Among authors: vertongen p. Peptides. 1997;18(10):1539-45. doi: 10.1016/s0196-9781(97)00228-3. Peptides. 1997. PMID: 9437714

10

Proline residue 280 in the second extracellular loop (EC2) of the VPAC2 receptor is essential for the receptor structure.

Vertongen P, Solano RM, Juarranz MG, Perret J, Waelbroeck M, Robberecht P. Vertongen P, et al. Peptides. 2001 Sep;22(9):1363-70. doi: 10.1016/s0196-9781(01)00476-4. Peptides. 2001. PMID: 11514016

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters